The efficacy of tocilizumab for adult-onset Still's disease
(The 15th Congress of Asisa Pacific League of Associations for Rheumatology 2012)
THE ADDITION OF ANOTHER DISEASE-MODIFYING ANTI-RHEUMATIC DRUG TO METHOTREXATE IN PLACE OF INFLIXIMAB IMPROVES THE RATE OF INFLIXIMAB-FREE SUSTAINED REMISSION:RESULTS FROM THE BuSHIDO TRIAL
(EULAR 2012)